International Urology and Nephrology · 2016 · 18 citations · 17 references
MedicineGeneticsMolecular GeneticsGenetic EpidemiologyHemodialysisMedical GeneticsCardiovascular DiseaseCoronary Artery DiseaseGenetic RiskRenal Artery DiseaseRenal DiseaseCardiovascular Genetic RiskCardiovascular Risk In HemodialysisCase-control Study DesignCoronary Artery Disease GeneticsLogistic RegressionLogistic Regression AnalysisRenal Enzyme MarkersRisk Factor Identification
PURPOSE: Coronary artery disease (CAD) is common in patients with end-stage renal disease (ESRD). Recent studies have suggested that renalase, a novel FAD-dependent amine oxidase, may play an important role in the pathogenesis of cardiovascular complications in ESRD patients. The aim of the study was to investigate the association between renalase gene polymorphisms and a risk of CAD in patients on hemodialysis. METHODS: In a case-control study, a total of 309 hemodialyzed patients (107 with and 202 without CAD) were genotyped for two SNPs in the renalase gene (rs10887800 and rs2576178) using the PCR-RFLP method. RESULTS: By multivariate logistic regression analysis, we found that rs10887800GG genotype was associated with an increased risk of CAD under the codominant model [GG vs AA; adjusted OR 2.66 (95 % CI, 1.19-5.94), p = .017] and under the recessive model [GG vs AG + AA; adjusted OR 2.10 (95 % CI, 1.10-4.02), p = .025]. The rs2576178 polymorphism did not influence the risk of CAD. CONCLUSION: The study suggested for the first time that the rs10887800 renalase gene polymorphism may be involved in the pathogenesis of CAD in hemodialyzed patients and thus could be considered a new genetic risk factor for CAD in this population.
17
Renalase deficiency aggravates ischemic myocardial damage
Yanling Wu, Jianchao Xu, Heino Velázquez et al. · Kidney International · 2010 · 152 citations
Medicine, Cardiology, Nephrology +11